Companies / South Korea
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Dong-A Targets Middle East
October 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Leading South Korean pharmaceuticals manufacturer Dong-A is to target the Middle Eastern market with its flagship erectile dysfunction (ED) product Zydena (udenafil). The firm is to export some US$30mn worth of the drug in partnership with an unidentified Saudi Arabian